American Society of HematologyHow I Treat Relapsed Acute Lymphoblastic Leukemia in the Pediatric Population
In the past decade, several promising immunotherapies have been developed, changing the treatment landscape for children with relapsed ALL. These advances in treatment offer real promise for less toxic and more effective therapy for children. In this article from Blood, the authors present several cases highlighting contemporary treatment decision-making.